| November 2019 |
|
|
The Medicare Program and the Coverage It Provides
|
|
|
Estimating Regulatory Savings
|
|
|
Medicare Part D Prescription Drug Coverage
|
| October 2019 |
|
|
Democrats Try to Curb Health Care Coverage
|
|
|
The Pelosi Drug Plan: Negotiation in Name Only
|
| September 2019 |
|
|
Investing in Americans' Health at the NIH
|
| August 2019 |
|
|
Myth vs. Fact on "Medicare for All"
|
| July 2019 |
|
|
Balancing Drug Innovation and Marketing Competition
|
| June 2019 |
|
|
Key Players in the Prescription Drug Market
|
| May 2019 |
|
|
Medicare Part D: The Noninterference Clause
|
|
|
Status of Social Security
|
| April 2019 |
|
|
Dems Target Affordable Health Care Again
|
| March 2019 |
|
|
Medicare for None: No Options, No Choice
|
| December 2018 |
|
|
Medicare for All: Higher Taxes, Fewer Choices, Longer Lines
|
| November 2018 |
|
|
Obamacare Alternative Gains Speed
|
| October 2018 |
|
|
S.J. Res. 63 – Disapproval of Short-Term Limited Duration Insurance Rule
|
|
|
H.R. 6 – Support for Patients and Communities Act
|
| September 2018 |
|
|
H.R. 302 (as amended), FAA Reauthorization Act of 2018
|
|
|
S. 2554 – Patient Right to Know Drug Prices Act
|
|
|
Senate Amendment to H.R. 6, The Opioid Crisis Response Act of 2018
|
